The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment

British Journal of Haematology

Volumn 107, Issue 1, 1999, Pages 148-153

  Rawstron, A C ^a   Rollinson, S J ^a   Richards, S ^a   Short, M A ^a   English, A ^a   Morgan, G J ^a   Hale, G ^b   Hillmen, Peter ^a,c,d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Therapeutic Antibody Centre   (United Kingdom)

^c PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

^d LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

CAMPATH 1H; Clonal selection; Dual pathogenesis; PNH

Indexed keywords

ALEMTUZUMAB; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; GLYCOSYLPHOSPHATIDYLINOSITOL; PENTOSTATIN; PREDNISOLONE; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOTHERAPY; MALE; MOLECULAR CLONING; NEUTROPENIA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; SOMATIC MUTATION; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; EXONS; FEMALE; FLOW CYTOMETRY; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0032736327     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01676.x     Document Type: Article

References (15)

1. -, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment. International Immunology, 8, 325-334.
2. Hale, G., Xia, M.Q., Tighe, H.P., Dyer, M.J.S. & Waldmann, H. (1990) The CAMPATH-1 antigen (CDw52). Tissue Antigens, 35, 118-127.
3. Hertenstein, B., Wagner, B., Bunjes, D., Duncker, C., Raghavachar, A., Arnold, R., Heimpel, H. & Schrezenmeier, H. (1995) Emergence of CD52, phosphatidyl-inositolglycan-anchor-deficient T-lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma. Blood, 86, 1487-1492.
4. Hillmen, P., Lewis, S.M., Bessler, M., Luzzatto, L. & Dacie, J.V. (1995) Natural history of paroxysmal nocturnal hemoglobinuria. New England Journal of Medicine, 333, 1253-1258.
5. Luzzatto, L. & Bessler, M. (1996) The dual pathogenesis of paroxysmal nocturnal haemoglobinuria. Current Opinions in Haematology, 3, 101-110.
6. Miyata, T., Takeda, J., Iida, Y., Yamada, N., Inoue, N., Takahashi, M., Maeda, K., Kitani, T. & Kinoshita, T. (1993) The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science, 259, 1318-1320.
7. Osterborg, A., Dyer, M.J.S., Bunjes, D., Pangalis, G.A., Bastion, Y., Catovsky, D. & Mellstedt, H. (1997) Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. Journal of Clinical Oncology, 15, 1567-1574.
8. Rosse, W.F. & Ware, R.E. (1995) The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood, 86, 3277-3286.
9. Rotoli, B. & Luzzatto, L. (1989) Paroxysmal nocturnal haemoglobinuria. Seminars in Haematology, 26, 201-207.
10. Schrezenmeier, H., Hertenstein, B., Wagner, B., Raghavachar, A. & Heimpel, H. (1995) A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by the high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. Experimental Hematology, 23, 81-87.
11. Socie, G., Mary, J.Y., de Gramont, A., Rio, B., Leporrier, M., Rose, C., Heudier, P., Rochant, H., Cahn, J.Y. & Gluckman, E. (1996) Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. Lancet, 348, 573-577.
12. Takeda, J., Miyata, T., Kawagoe, K., Iida, Y., Endo, Y., Fujita, T., Takahashi, M., Kitani, T. & Kinoshita, T. (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell, 73, 703-711.
13. Taylor, V.C., Sims, M., Brett, S. & Field, M.C. (1997) Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism. Biochemical Journal, 322, 919-925.
14. Yamada, N., Miyata, T., Maeda, K., Kitani, T., Takeda, J. & Kinoshita, T. (1995) Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocutrnal hemoglobinuria. Blood, 85, 885-892.
15. Young, N.S. & Barrett, A.J. (1995) The treatment of acquired aplastic anemia. Blood, 85, 3367-3377.